Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTL | Q8NG68 | 13/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | BCHE | P06276 | 2/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8733664 | 0.80 | TTL (0.51) | TTLMAPTBCHEACHEHSD11B1 | |
| SCHEMBL8733662 | 0.80 | TTL (0.51) | TTLMAPTBCHEACHEHSD11B1 | |
| Isoabienol SCHEMBL20640862 | 0.70 | ALDH1A1 (0.64) | CYP3A4MEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL8733660 | 0.66 | TTL (0.39) | TTLCYP3A4MEN1ALDH1A1MAPT | |
| SCHEMBL30780864 | 0.61 | HSD11B1 (0.46) | CYP3A4LMNASMN1; SMN2BCHEACHE | |
| SCHEMBL8733677 | 0.60 | MAPT (0.44) | TTLCYP3A4MEN1ALDH1A1MAPT | |
| SCHEMBL8733674 | 0.60 | MAPT (0.44) | TTLCYP3A4MEN1ALDH1A1MAPT | |
| SCHEMBL19844093 | 0.60 | CYP3A4 (0.36) | CYP3A4MEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL5704147 | 0.58 | ALDH1A1 (0.64) | CYP3A4MEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL11097042 | 0.58 | LSS (0.38) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230381135-A1 | COMPOSITION COMPRISING AT LEAST ONE LABDANE DITERPENE AND METHOD FOR MANUFACTURING SAME | ELEONOR (BE) | 2023-11-30 | — | — | US | claimed |
| EP-4228604-A1 | COMPOSITION COMPRISING AT LEAST ONE LABDANE DITERPENE AND METHOD FOR MANUFACTURING SAME | Tilman (BE) | 2023-08-23 | — | — | EP | claimed |
| WO-2022079090-A1 | COMPOSITION COMPRISING AT LEAST ONE LABDANE DITERPENE AND METHOD FOR MANUFACTURING SAME | TILMAN SA (BE) | 2022-04-21 | — | — | WO | claimed |
| CN-119343400-A | Sealing film and sealing composition for sealing microcells of electro-optical devices | 伊英克公司 | 2025-01-21 | — | — | CN | disclosed |
| US-20230381135-A1 | COMPOSITION COMPRISING AT LEAST ONE LABDANE DITERPENE AND METHOD FOR MANUFACTURING SAME | ELEONOR (BE) | 2023-11-30 | — | — | US | disclosed |
| EP-4228604-A1 | COMPOSITION COMPRISING AT LEAST ONE LABDANE DITERPENE AND METHOD FOR MANUFACTURING SAME | Tilman (BE) | 2023-08-23 | — | — | EP | disclosed |
| WO-2022079090-A1 | COMPOSITION COMPRISING AT LEAST ONE LABDANE DITERPENE AND METHOD FOR MANUFACTURING SAME | TILMAN SA (BE) | 2022-04-21 | — | — | WO | disclosed |
| EP-3796898-A1 | COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN USING HYALURONIC ACID AND EGGSHELL MEMBRANE COMPONENTS | U.S. Nutraceuticals, LLC d/b/a Valensa International (US) | 2021-03-31 | — | — | EP | disclosed |
| US-7795302-B2 | Use of compositions for treating rosacea | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2010-09-14 | — | — | US | disclosed |
| US-20080070874-A1 | using retinoid or tetracycline as bactericide, benzoyl peroxide as metalloproteinases (MMPs) and neutrophil elastase inhibitors; antiscarring agents; reduction in procollagen biosynthesis | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2008-03-20 | — | — | US | disclosed |
| US-7268148-B2 | Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes | REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2007-09-11 | — | — | US | disclosed |
| EP-1385496-A4 | USE OF COMPOSITIONS FOR TREATING ROSACEA | UNIV MICHIGAN (US) | 2006-03-29 | — | — | EP | disclosed |
| US-20060009494-A1 | Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes | VOORHEES JOHN J | 2006-01-12 | — | — | US | disclosed |
| US-20050277695-A1 | Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes | VOORHEES JOHN J | 2005-12-15 | — | — | US | disclosed |
| US-20040235950-A1 | Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes | REGENTS OF THE UNIVERSITY OF MICHIGAN, THE | 2004-11-25 | — | — | US | disclosed |
| EP-1385496-A2 | USE OF COMPOSITIONS FOR TREATING ROSACEA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2004-02-04 | — | — | EP | disclosed |
| EP-1284721-A2 | COMPOSITIONS AND METHODS FOR USE AGAINST ACNE-INDUCED INFLAMMATION AND DERMAL MATRIX-DEGRADING ENZYMES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2003-02-26 | — | — | EP | disclosed |
| US-20020183399-A1 | Method and compositions for treating rosacea | REGENTS OF THE UNIVERSITY OF MICHIGAN, THE | 2002-12-05 | — | — | US | disclosed |
| WO-2002089743-A2 | USE OF COMPOSITIONS FOR TREATING ROSACEA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2002-11-14 | — | — | WO | disclosed |
| WO-2001089502-A2 | COMPOSITIONS AND METHODS FOR USE AGAINST ACNE-INDUCED INFLAMMATION AND DERMAL MATRIX-DEGRADING ENZYMES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2001-11-29 | — | — | WO | disclosed |